Impact of outpatient antibiotic use on carriage of ampicillin-resistant Escherichia coli

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 3, 2011, Pages 1135-1141

  Samore, Matthew H ^a,b   Tonnerre, Claude ^b,e   Hannah, Elizabeth Lyon ^b   Stoddard, Gregory J ^b   Borotkanics, Robert J ^c   Haddadin, Bassam ^b   Harbarth, Stephan ^d  

^a IDEAS Research Center   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e St Patrick Hospital and Health Sciences Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; MACROLIDE; NALIDIXIC ACID; PENICILLIN G; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN;

ADOLESCENT; ADULT; AMPICILLIN RESISTANT ECHERICHIA COLI; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CLUSTER ANALYSIS; COMPETITIVE BEHAVIOR; CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG EXPOSURE; DRUG USE; ESCHERICHIA COLI; FAMILY; FECES ANALYSIS; FEMALE; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCHOOL CHILD;

ADOLESCENT; AMPICILLIN; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; OUTPATIENTS;

EID: 79952348539     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01708-09     Document Type: Article

References (21)

1. Brun, E., G. Holstad, H. Kruse, and J. Jarp. 2002. Within-sample and between-sample variation of antimicrobial resistance in fecal Escherichia coli isolates from pigs. Microb. Drug Resist. 8:385-391.
2. Clinical Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing, vol. 27: 17th informational supplement. CLSI document M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Donnan, P. T., et al. 2004. Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data. BMJ 328:1297.
4. Fantin, B., et al. 2009. Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. J. Infect. Dis. 200:390-398.
5. Grenet, K., et al. 2004. Antibacterial resistance, Wayampis Amerindians, French Guyana. Emerg. Infect. Dis. 10:1150-1153.
6. Harbarth, S., A. D. Harris, Y. Carmeli, and M. H. Samore. 2001. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin. Infect. Dis. 33:1462-1468.
7. Harbarth, S., and M. H. Samore. 2005. Antimicrobial resistance determinants and future control. Emerg. Infect. Dis. 11:794-801.
8. Hay, A. D., et al. 2005. The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data. J. Antimicrob. Chemother. 56:146-153.
9. Huang, D. B., Z. D. Jiang, C. D. Ericsson, J. Adachi, and H. L. Dupont. 2001. Emergence of trimethoprim-resistant Escherichia coli in healthy persons in the absence of prophylactic or therapeutic antibiotics during travel to Guadalajara, Mexico. Scand. J. Infect. Dis. 33:812-814. (Pubitemid 33069517)
10. Johnson, J. R., K. Owens, A. Gajewski, and C. Clabots. 2008. Escherichia coli colonization patterns among human household members and pets, with attention to acute urinary tract infection. J. Infect. Dis. 197:218-224.
11. Lietzau, S., E. Raum, H. von Baum, R. Marre, and H. Brenner. 2007. Household contacts were key factor for children's colonization with resistant Escherichia coli in community setting. J. Clin. Epidemiol. 60:1149-1155.
12. Lipsitch, M., and M. H. Samore. 2002. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg. Infect. Dis. 8:347-354.
13. Murray, B. E., J. J. Mathewson, H. L. DuPont, C. D. Ericsson, and R. R. Reves. 1990. Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents. Antimicrob. Agents Chemother. 34:515-518.
14. Murray, B. E., E. R. Rensimer, and H. L. DuPont. 1982. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole. N. Engl. J. Med. 306:130-135.
15. Raum, E., S. Lietzau, H. von Baum, R. Marre, and H. Brenner. 2008. Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany. Clin. Microbiol. Infect. 14:41-48.
16. Reves, R. R., M. Fong, L. K. Pickering, A. Bartlett III, M. Alvarez, and B. E. Murray. 1990. Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas. Antimicrob. Agents Chemother. 34:1429-1434. (Pubitemid 20215787)
17. Samore, M. H., et al. 2001. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics 108:856-865. (Pubitemid 32947653)
18. Sundqvist, M., et al. 2010. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J. Antimicrob. Chemother. 65:350-360.
19. Tacconelli, E. 2009. Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings. Curr. Opin. Infect. Dis. 22:352-358.
20. Valverde, A., et al. 2008. High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J. Clin. Microbiol. 46:2796-2799.
21. van de Mortel, H. J., et al. 1998. The prevalence of antibiotic-resistant faecal Escherichia coli in healthy volunteers in Venezuela. Infection 26:292-297.